Cancer Research and Treatment

Pre-treatment Ki67 index for everolimus efficacy in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer: A multicenter cohort study

Breast Cancer Research

Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread

Cancers

The prognostic and predictive value of body mass index in patients with HR+/HER2- breast cancer treated with CDK4/6 inhibitors: A systematic literature review

Future Oncology

OPERA-01: A phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy

Journal of Clinical Oncology

Efficacy and safety of elinzanetant for vasomotor symptoms associated with adjuvant endocrine therapy: Phase 3 OASIS 4 trial

Cancers

CDK4/6 inhibitors plus endocrine therapy in early-stage HR+/HER2- breast cancer: Updated meta-analysis of phase III trials

JAMA Oncology

Vaginal estrogen therapy use and survival in females with breast cancer

Journal of Surgical Oncology

Do racial and income disparities exist in the application of 21-gene recurrence score?

Journal of Clinical Oncology

Single center study of efficacy and safety of capivasertib in hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC)

Science Progress

Advancements in non-invasive biomarkers for detection and monitoring of breast cancer recurrence